BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15159027)

  • 21. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model.
    Mönckedieck V; Sannecke C; Husen B; Kumbartski M; Kimmig R; Tötsch M; Winterhager E; Grümmer R
    Mol Hum Reprod; 2009 Oct; 15(10):633-43. PubMed ID: 19671596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma.
    Pijnenborg JM; Romano A; Dam-de Veen GC; Dunselman GA; Fischer DC; Groothuis PG; Kieback DG
    J Pathol; 2005 Apr; 205(5):597-605. PubMed ID: 15726651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
    Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
    Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progesterone receptor's profile and the effect of the hormone and its derivatives on invasiveness and MMP2 secretion in endometrial carcinoma cell lines].
    Zafran N; Levin A; Goldman S; Shalev E
    Harefuah; 2009 Jul; 148(7):416-9, 477. PubMed ID: 19848324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
    Huang CS; Fan YE; Lin CY; Hu ML
    J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
    Chen MH; Cui SX; Cheng YN; Sun LR; Li QB; Xu WF; Ward SG; Tang W; Qu XJ
    Anticancer Drugs; 2008 Nov; 19(10):957-65. PubMed ID: 18827560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
    Chen SH; Gillespie GY; Benveniste EN
    Glia; 2006 Jan; 53(2):191-200. PubMed ID: 16206166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line].
    Hou YF; Yuan ST; Li HC; Wu J; Lu JS; Lu LJ; Liu G; Shen ZZ; Ding J; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):389-92. PubMed ID: 16188119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
    Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D
    Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment.
    Yoshimura T; Sumida T; Liu S; Onishi A; Shintani S; Desprez PY; Hamakawa H
    Endocr Relat Cancer; 2007 Dec; 14(4):1107-16. PubMed ID: 18045962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
    Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Kim WB; Kim SH; Lee SK
    Biochem Pharmacol; 2005 Dec; 71(1-2):21-31. PubMed ID: 16271263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology.
    Guay S; Akoum A
    Reproduction; 2007 Sep; 134(3):525-34. PubMed ID: 17709570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
    Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S
    Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
    Monge M; Colas E; Doll A; Gonzalez M; Gil-Moreno A; Planaguma J; Quiles M; Arbos MA; Garcia A; Castellvi J; Llaurado M; Rigau M; Alazzouzi H; Xercavins J; Alameda F; Reventos J; Abal M
    Cancer Res; 2007 Jul; 67(14):6753-9. PubMed ID: 17638886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
    J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
    Oh JH; Kim JH; Ahn HJ; Yoon JH; Yoo SC; Choi DS; Lee IS; Ryu HS; Min CK
    Gynecol Oncol; 2009 Sep; 114(3):509-15. PubMed ID: 19539355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
    Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
    Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.